×
About 398,028 results

Study finds higher risk of skin cancer after childhood organ transplant
https://www.mdedge.com/dermatology/article/255839/nonmelanoma-skin-cancer/study-finds-higher-risk-skin-cancer-after
Christine Kilgore

Jun 28th, 2022 - A large study showing an increased risk of keratinocyte carcinoma (KC) in children who receive a solid-organ transplant highlights the need for early education about risk reduction and more research to determine optimal timing for screening, say an investigator and two dermatologists with expertise in transplant-related skin issues. The increased incidence of KC in pediatric transplant recipien.

Good chemo vs. bad chemo: When too much is a bad thing
https://www.mdedge.com/hematology-oncology/article/255824/renal-cell-carcinoma/good-chemo-vs-bad-chemo-when-too-much-bad
Randy Dotinga

Jun 28th, 2022 - A new study finds that mortality is significantly higher among patients with advanced solid tumors who are admitted to the hospital for chemotherapy treatment. The findings – released in a poster session at the annual meeting of the American Society of Clinical Oncology – found that patients with solid tumors were more likely to be treated for nonurgent indications, not be referred to palliativ.

Racial/ethnic disparities exacerbated maternal death rise during 2020 pandemic.
https://www.mdedge.com/obgyn/article/255812/covid-19-updates/racial/ethnic-disparities-exacerbated-maternal-death-rise
Diana Swift

Jun 28th, 2022 - U. S.

Abortion pills over the counter? Experts see major hurdles in widening U.S. access
https://www.mdedge.com/obgyn/article/255808/business-medicine/abortion-pills-over-counter-experts-see-major-hurdles
Ahmed Aboulenein

Jun 28th, 2022 - WASHINGTON (Reuters) – A pill used to terminate early pregnancies is unlikely to become available without a prescription for years, if ever, experts told Reuters, as the conservative-leaning U. S.

My picks for best of ASCO 2022
https://www.mdedge.com/hematology-oncology/article/255805/asco-lung-cancer/my-picks-best-asco-2022
David H. Henry, MD

Jun 28th, 2022 - CHICAGO – The American Society of Clinical Oncology recently wrapped its annual meeting in Chicago. Many of us attended virtually, or in person, and were wowed by some of the abstracts and their implications for our patients – some practice changing.

Melanoma incidence is up, but death rates are down
https://www.mdedge.com/hematology-oncology/article/255799/melanoma/melanoma-incidence-death-rates-are-down
Jim Kling

Jun 28th, 2022 - CHICAGO – Mortality rates from melanoma have fallen in recent years, likely due to the introduction of checkpoint inhibitors, according to a new analysis of the National Cancer Institute SEER database between 1975 and 2019. “This is very encouraging data and represents the real-world effectiveness of these therapies.

Highlights in Early-Stage Non–Small Cell Lung Cancer From ASCO 2022
https://www.mdedge.com/hematology-oncology/article/255791/asco-lung-cancer/highlights-early-stage-non-small-cell-lung
Howard (Jack) West, MD

Jun 28th, 2022 - Highlights in early-stage non–small lung cancer (NSCLC) from the 2022 American Society of Clinical Oncology Annual Meeting are discussed by Dr Jack West of City of Hope Comprehensive Cancer Center in Duarte, California. He opens with a post hoc analysis of CheckMate 816, which showed that achieving a pathologic complete response with adjuvant nivolumab plus chemotherapy was highly associated wi.

Highlights in Early-Stage Non–Small Cell Lung Cancer From ASCO 2022
https://www.mdedge.com/hematology-oncology/article/255791/conference-recap/highlights-early-stage-non-small-cell-lung
Howard (Jack) West, MD

Jun 28th, 2022 - Highlights in early-stage non–small lung cancer (NSCLC) from the 2022 American Society of Clinical Oncology Annual Meeting are discussed by Dr Jack West of City of Hope Comprehensive Cancer Center in Duarte, California. He opens with a post hoc analysis of CheckMate 816, which showed that achieving a pathologic complete response with adjuvant nivolumab plus chemotherapy was highly associated wi.

Establishing a formalized mentorship program in a community practice
https://www.mdedge.com/gihepnews/article/255776/practice-management/establishing-formalized-mentorship-program-community
Marc Sonenshine, MD

Jun 27th, 2022 - Most GI physicians will tell you that we didn’t get where we are without help along the way. Each of us can point to one – or in most cases, several – specific mentors who provided invaluable guidance when we were in medical school, fellowship, and starting our careers.

FDA approves liso-cel as second-line therapy for LBCL
https://www.mdedge.com/hematology-oncology/article/255765/b-cell-lymphoma/fda-approves-liso-cel-second-line-therapy-lbcl
Sharon Worcester

Jun 27th, 2022 - Lisocabtagene maraleucel, also known as liso-cel (Breyanzi), has been approved by the Food and Drug Administration for the second-line treatment of adult patients with relapsed or refractory large B-cell lymphoma (r/r LBCL). This expanded indication is based on findings from the pivotal phase 3 TRANSFORM study, which showed significant and clinically meaningful improvements with CD19-directed c.

Fast Five Quiz: Metastatic Hormone-Sensitive Prostate Cancer Treatment
https://www.medscape.com/viewarticle/921254

Jun 27th, 2022 - The incidence of metastatic hormone-sensitive prostate cancer (mHSPC) has significantly increased in recent years, in part due to advancements in imaging technology. Men with metastatic prostate cancer who have not received prior treatment with androgen deprivation therapy (ADT) or who are still sensitive to ADT and do not have castration-resistant cancer are defined as having mHSPC, a lethal d...

ECG Challenge: Uncontrolled COPD or Something Else?
https://www.medscape.com/viewarticle/975590

Jun 27th, 2022 - A 70-year-old man with a history of chronic obstructive pulmonary disease (COPD), treated with inhalers, presents to his pulmonologist with worsening shortness of breath which he thinks is related to COPD. He has noted intermittent palpitations. His physician checks his blood pressure, which is 100/70 mm Hg, and notes a rapid heart rate, prompting an ECG. Figure 1. Courtesy of Philip J. Podrid,...

Use of Statins for Primary Prevention Tied to Lower Risk of Hospitalization for COVID-19
https://www.medscape.com/viewarticle/976151

Jun 27th, 2022 - NEW YORK (Reuters Health) - Patients taking statins for primary prevention of cardiovascular disease may have a lower risk of hospitalization for COVID-19 than matched individuals not taking the medications, a large new study suggests. An analysis of data from more than 2 million statin users and a similar number of matched controls revealed a 16% lower risk of hospitalization for COVID-19 amon...

Restricting Abortion Just Makes It More Deadly, Says UN After US Ruling
https://www.medscape.com/viewarticle/976173

Jun 27th, 2022 - (Reuters) - Restricting abortion access does not stop people seeking the procedure "it only makes it more deadly," a spokesman for U.N. Secretary-General Antonio Guterres said on Friday after the U.S. Supreme Court overturned a 1973 decision legalizing abortion. "Sexual and reproductive health and rights are the foundation of a life of choice, empowerment and equality for the world's women and ...

ASCO 2022: Data for Better Decision-Making in the Treatment of Advanced Bladder Cancer
https://www.medscape.com/viewarticle/976182

Jun 27th, 2022 - Tracy L. Rose, MD, MPH, shares the immediate and direct impact of the long-term follow-up data from the JAVELIN Bladder 100 trial, an avelumab maintenance study in patients with advanced urothelial carcinoma, which was part of a poster session at the 2022 ASCO annual meeting. The results of the 38-month follow-up data showed prolonged overall survival in patients using first-line avelumab maint...

Abortion Pills Over the Counter? Experts See Major Hurdles in Widening US Access
https://www.medscape.com/viewarticle/976181

Jun 27th, 2022 - WASHINGTON (Reuters) - A pill used to terminate early pregnancies is unlikely to become available without a prescription for years, if ever, experts told Reuters, as the conservative-leaning U.S. Supreme Court dramatically curbed abortion rights this week. The Supreme Court on Friday overturned the landmark 1973 Roe v. Wade ruling that recognized the constitutional right to an abortion and lega...

Another Public Health Crisis Originating From Gun Violence
https://www.medscape.com/viewarticle/976178

Jun 27th, 2022 - The number of mass shootings in the US has jumped from 272 annually in 2014 to 692 annually in 2021. As these attacks have increased in frequency, averaging more than once daily since 2019, we've slowly become accustomed to their occurrence. Now, guns only reenter the national conversation when there is a particularly devastating event. Most recently, a shooting in an elementary school in Uvald...

COVID-19 Tied to Increased Risk for Alzheimer's, Parkinson's Disease
https://www.medscape.com/viewarticle/976244

Jun 27th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 has been associated with a threefold increased risk of Alzheimer's disease (AD) and a doubling of Parkinson's disease (PD) risk, a new study suggests. However, the research also showed there was no excess risk of these neurologic disorders following COVID than other respiratory infectio...

Post-Roe v. Wade: What’s Next?
https://www.medscape.com/viewarticle/976278

Jun 27th, 2022 - Friday's U.S. Supreme Court decision to overturn Roe v. Wade, the landmark ruling in 1973 establishing a constitutional right to abortion, has spurred abortion rights supporters and opponents into action, speeding up their efforts to protect or remove access to abortion. For now, the fight moves to the states, where so-called trigger laws have already banned nearly all abortions in a handful of...

Alcohol Consumption Habits Can Predict Gout Tophi
https://www.medscape.com/viewarticle/976282

Jun 27th, 2022 - The more years a person drinks alcohol, the kind of alcohol consumed, and the amount consumed can help to predict gout tophi, researchers say in a newly published paper in Arthritis Care and Research. The study, led by Lin Han, PhD, of the gout laboratory, Shandong provincial clinical research center for immune diseases and gout, Affiliated Hospital of Qingdao (China) University, helps clarify ...